US short seller
The drug maker’s market capitalization has fallen by more than €3 billion ($3.15 billion) since Gotham published a report accusing the company of overstating its profits and understating its debt. Grifols, which has denied any wrongdoing,
Gotham, run by
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
